Originally published by Quantzig: Patient Journey Analytics for a Leading Pharma Company
"The Vital Role of Patient Journey Analytics in the Pharma Industry"
Patient journey analytics delves into every stage of a patient's experience, from symptom awareness to disease progression and treatment. It encompasses interactions with various stakeholders, including doctors, healthcare providers, and payers, capturing decisions made, the reasoning behind them, and the emotions involved. This comprehensive approach provides both quantitative data and qualitative insights, shaping a detailed understanding of patients, caregivers, and providers throughout the healthcare journey.
In a fiercely competitive landscape influenced by healthcare regulations, organizations in the pharmaceutical sector are increasingly prioritizing the understanding of patient journeys. The focus is on demonstrating the effective use of technology to enhance patient care, satisfaction levels, and overall experiences. A well-crafted patient journey lays the groundwork for successful brand strategies, allowing pharmaceutical companies to navigate the complexities of the market.
Quantzig's patient journey analytics services, tailored to the evolving healthcare landscape, empower pharmaceutical companies to identify optimal drug and treatment patterns. Through insightful analyses, we offer a 360° view of the patient journey, supporting manufacturers in making informed decisions that align with individual patient characteristics.
**Navigating the Pharma Landscape with Patient Journey Analytics: A Case Study**
**Client Profile:** A leading pharmaceutical corporation in the United States.
**Business Challenge:** The client sought a comprehensive understanding of the patient journey for individuals diagnosed with Crohn’s disease.
**Quantzig’s Approach:** Our patient journey analysis aimed to provide a holistic perspective on drug performance in real-world scenarios compared to ideal settings. Leveraging real-world data, the study validated clinical trial efficacy by assessing disease progression in patients under various therapies. Insights were gleaned on the impact of drug adherence on disease progression and flare-ups.
**Business Benefits and Insights:**
- Real-time insights on drug performance in real-world conditions.
- Identification of optimal treatment patterns through the analysis of claims data.
- Development of a validation framework to assess clinical trial efficacy against real-world data.
- Mapping of the entire patient treatment path using various data sources, including laboratory results, demographics, radiology reports, pharmacy information, hospital admissions, discharge summaries, and progress notes.
The results revealed low adherence rates to high drug dosages, higher adherence rates in patients with less strength and non-comorbid conditions, and a 30% higher risk of surgery for smokers compared to non-smokers. Additionally, patients from urban and industrialized areas faced a higher disease risk than those in rural regions.
QuantZig's patient journey analytics equips pharmaceutical companies with actionable insights, guiding strategic decisions and enhancing patient outcomes.
